In the present study, with the aim of exploring the underlying mechanisms of sorafenib resistance in patients with HCC, we conducted RNA sequencing to identify significant changes in signaling pathway between CHAF1B-interfered HCC cell lines, HepG2 and their control cell lines. Here, CHAF1B is linked to hepatocellular carcinoma.